Mohammad Zahid Ashraf
Mohammad Zahid Ashraf is a prominent figure in the field of biomedical science, with a particular focus on thrombosis and haemostasis. His research has significantly contributed to the understanding of the molecular mechanisms underlying blood coagulation and its disorders, which has implications for the development of new therapeutic strategies for preventing and treating thrombotic diseases.
Early Life and Education[edit | edit source]
Mohammad Zahid Ashraf was born in India. He pursued his higher education in the field of Life Sciences, specializing in Biochemistry. Ashraf earned his Ph.D. in Biochemistry, focusing on the molecular aspects of human diseases, which laid the foundation for his future research career in thrombosis and haemostasis.
Career and Research[edit | edit source]
After completing his Ph.D., Ashraf embarked on a career in biomedical research, with a focus on understanding the complex processes of thrombosis and haemostasis. He has worked in several prestigious research institutions, contributing to the advancement of knowledge in his field.
His research work involves the study of genetic and molecular factors that influence blood coagulation, the role of platelets in thrombosis, and the identification of novel biomarkers for thrombotic diseases. Ashraf's work has led to the development of potential therapeutic targets for the prevention and treatment of conditions such as deep vein thrombosis and pulmonary embolism.
Contributions and Achievements[edit | edit source]
Mohammad Zahid Ashraf has published numerous research articles in high-impact scientific journals. His contributions to the field of thrombosis and haemostasis have been recognized with several awards and honors. He is also an active member of various professional societies related to his field of research, where he contributes to the dissemination of knowledge and the advancement of biomedical science.
Legacy and Future Directions[edit | edit source]
Ashraf's work continues to influence the field of thrombosis and haemostasis. His ongoing research aims to further elucidate the molecular mechanisms of blood coagulation disorders and to explore innovative therapeutic approaches. Through his dedication and contributions, Mohammad Zahid Ashraf is helping to pave the way for improved management and treatment of thrombotic diseases, potentially benefiting patients worldwide.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD